Cytomx Therapeutics (CTMX)Orbimed Advisors LLC opened a new position $19.2M

8.46M

Shares reported

0.48%

Disclosed portfolio weight

$19.2M

Reported value

Holdings as of

Jun 30, 2025

Filed

Aug 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 13, 2025InsiderCFO sold ~$4.8K of CTMX shares in the open market
2. Jun 16, 2025Insider · 3 peopleInsiders: 3 sales (~$215K)

What came next

1. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Cytomx Therapeutics

For Cytomx Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CTMX page.

How this filing works

• SEC Form 13F

Other disclosures at Cytomx Therapeutics

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 29, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 14, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRNov 14, 2025

Everything OQRO holds on this company is on its CTMX page.